Search filters

List of works by Elena Quaglino

2H,3H-decafluoropentane-based nanodroplets: new perspectives for oxygen delivery to hypoxic cutaneous tissues

scientific article

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins

scientific article published on 23 March 2010

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia

scientific article published on 01 April 2001

A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.

scientific article

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.

scientific article published in January 2000

Antitumor immunization of mothers delays tumor development in cancer-prone offspring.

scientific article published on 3 February 2015

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2(+) mammary cancer

scientific article published on 31 August 2015

CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA

scientific article published on 29 May 2014

Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers

scientific article

Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans

scientific article published on 10 August 2011

Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

article

Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues

scientific article published on 2 March 2015

DNA immunization using constant-current electroporation affords long-term protection from autochthonous mammary carcinomas in cancer-prone transgenic mice

scientific article published on 09 November 2007

DNA vaccination against oncoantigens: A promise

scientific article published on May 2012

Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice.

scientific article published on 12 September 2013

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

scientific article

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

scientific article published on 16 August 2011

Identification of relevant conformational epitopes on the HER2 oncoprotein by using Large Fragment Phage Display (LFPD).

scientific article

Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario

scientific article

Immunization against ROS1 by DNA Electroporation Impairs K-Ras-Driven Lung Adenocarcinomas

scientific article published on 06 April 2020

Immunological prevention of spontaneous tumors: a new prospect?

scientific article published on 01 February 2002

Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice

scientific article published in March 2001

Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

scientific article published in March 2001

Interleukin 12-activated lymphocytes influence tumor genetic programs

scientific article published on 01 April 2001

Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells

scientific article

Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice

scientific article published on 30 April 2014

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

scientific article

Oncoantigens as anti-tumor vaccination targets: the chance of a lucky strike?

article by Raffaele A. Calogero et al published 20 February 2008 in Cancer Immunology, Immunotherapy

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity

scientific article published on 13 September 2016

Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain.

scientific article published on March 2008

Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013

article

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

scientific article published on 10 March 2018

The Promise of Preventive Cancer Vaccines

scientific article

The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice.

scientific article published on May 2005

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis.

scientific article published on 8 November 2016

The rat ErbB2 tyrosine kinase receptor produced in plants is immunogenic in mice and confers protective immunity against ErbB2(+) mammary cancer.

scientific article

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2.

scientific article published on 23 January 2014

Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.

scientific article published on December 2010

miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2.

scientific article published on 23 April 2013

miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.

scientific article published on 10 May 2013

miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1.

scientific article published on 11 December 2012

microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C.

scientific article

Paulina is supported by:

About Paulina

Help